Niel, Belgium – February 19th, 2026 – etherna, a leading provider of cutting-edge mRNA and lipid nanoparticle (LNP) technology across…
Read more: etherna´s intratumoral mRNA/LNP platform advances to clinical testing in non-melanoma skin cancer led by Almirall